Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
polytaurine
- Development stage
- Preclinical
- Lead developer
- West China Hospital of Sichuan University
- Administration
- Intravitreal
01
Overview
Polytaurine is a synthetic polymer biomaterial composed of polymerized taurine. It is being developed as a hydrogel-based intraocular tamponade for use in vitreoretinal surgery, such as for the treatment of retinal detachment. Due to its hydrophilicity, biocompatibility, and sulfur-containing structure, polytaurine-based hydrogels can match the viscosity and optical properties required to replace vitreous humor while preserving retinal structure and function.
- Other names
- poly(taurine)
Beyond the preview
Go deeper on polytaurine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on polytaurine.